Clinical Trial Update: The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 study from National Taiwan University Hospital completed evaluating susceptibility test–driven sequential therapy as a third-line treatment for refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED